SBC Medical Group CEO and Doctors Present at the 114th JSAS Conference
Key facts
- SBC Medical Group CEO and Doctors Present at the 114th JSAS Conference
- SBC Medical Group CEO Yoshiyuki Aikawa chaired a symposium and 5 network doctors presented clinical research at the 114th Japan Society of Aesthetic Surgery (JSAS) held in Tokyo on May 28-29, 2026.
- Source: PR Times
- Date: June 5, 2026
Direct answer
SBC Medical Group CEO Yoshiyuki Aikawa chaired a symposium and 5 network doctors presented clinical research at the 114th Japan Society of Aesthetic Surgery (JSAS) held in Tokyo on May 28-29, 2026.
- Citation
- SBC Medical Group CEO and Doctors Present at the 114th JSAS Conference (June 5, 2026), PR Times
- Source
- PR Times
- Date
- June 5, 2026
SBC Medical Group CEO Yoshiyuki Aikawa chaired a symposium and 5 network doctors presented clinical research at the 114th Japan Society of Aesthetic Surgery (JSAS) held in Tokyo on May 28-29, 2026.
📋 Article Processing Timeline
- 📰 Published: June 5, 2026 at 11:00
- 🔍 Collected: June 5, 2026 at 11:27 (27 min after Published)
- 🤖 AI Analyzed: June 6, 2026 at 18:06 (30h 39m after Collected)
SBC Medical Group Holdings Inc. (Irvine, CA; CEO: Yoshiyuki Aikawa) participated in the 114th Japan Society of Aesthetic Surgery (JSAS) held at The Okura Tokyo on May 28-29, 2026, under the theme 'Tradition Meets Innovation from Japan'. CEO Aikawa chaired a symposium focused on integrating medicine, marketing, customer management, and AI technology to lead discussion on future aesthetic medicine from a management perspective. Five doctors from the SBC clinic network also presented research across various sessions. Dr. Keiichiro Kasai discussed hair regeneration and anti-aging treatments. Dr. Soichiro Morikawa presented on skin rejuvenation combination therapies and polynucleotide clinical applications. Dr. Daisuke Sato showcased SMAS sub-dissection in facelifts. Dr. Shunsuke Nagakura evaluated the utility of artificial dermis in nasolabial fold treatments based on 50 cases. Dr. Atsushi Hayashi presented on adverse events related to botulinum toxin injections in the cheek. SBC remains committed to promoting advanced initiatives and improving safety, transparency, and sustainable value in aesthetic medicine.
FAQ
第114回日本美容外科学会はいつどこで開催されましたか？
2026年5月28日〜29日にThe Okura Tokyoで開催されました。
学会の公式サイトのURLは何ですか？
https://square.umin.ac.jp/jsas114/index.html です。
SBCメディカルグループホールディングスの代表者と本社の所在地はどこですか？
CEOは相川佳之氏で、所在地は米国カリフォルニア州（200 Spectrum Center Drive Suite 300 Irvine, CA 92618 USA）です。
学会で発表された主な研究テーマにはどのようなものがありますか？
薄毛治療、フェイスリフトにおけるSMAS下剥離、法令線治療における人工真皮の有用性、ボツリヌストキシン製剤注入の有害事象、ポリヌクレオチド製剤の臨床応用などがあります。
SBCメディカルグループの主な事業内容と上場市場は何ですか？
医療機関への経営支援事業を行っており、米国NASDAQ市場（ティッカー：SBC）に上場しています。